Yi-Jong Lin
General Counsel bei TaiGen Biotechnology Co., Ltd.
Profil
Yi-Jong Lin is a professional who currently holds the position of Vice President-Regulatory Affairs at TaiGen Biotechnology Co., Ltd.
Prior to this, he worked as a Principal at Colgate-Palmolive Co. and Eisai Medical Research, Inc. Dr. Lin received his graduate and doctorate degrees from the University of Tokyo.
Aktive Positionen von Yi-Jong Lin
| Unternehmen | Position | Beginn |
|---|---|---|
TaiGen Biotechnology Co., Ltd.
 TaiGen Biotechnology Co., Ltd. Pharmaceuticals: MajorHealth Technology TaiGen Biotechnology Co., Ltd. is a research-based and product-driven pharmaceutical company engaging in the development of therapeutics for infectious diseases, cancer, and diabetes-related complications. Its activities include drug discovery, development, global regulatory, and commercialization in China. The company was founded by Ming-Chu Hsu in 2001 and is headquartered in Taipei, Taiwan. | General Counsel | 11.01.2010 |
Ehemalige bekannte Positionen von Yi-Jong Lin
| Unternehmen | Position | Ende |
|---|---|---|
| COLGATE-PALMOLIVE COMPANY | Corporate Officer/Principal | - |
| Eisai Medical Research, Inc. | Corporate Officer/Principal | - |
Ausbildung von Yi-Jong Lin
| University of Tokyo | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| COLGATE-PALMOLIVE COMPANY | Consumer Non-Durables |
| Private Unternehmen | 2 |
|---|---|
TaiGen Biotechnology Co., Ltd.
TaiGen Biotechnology Co., Ltd. Pharmaceuticals: MajorHealth Technology TaiGen Biotechnology Co., Ltd. is a research-based and product-driven pharmaceutical company engaging in the development of therapeutics for infectious diseases, cancer, and diabetes-related complications. Its activities include drug discovery, development, global regulatory, and commercialization in China. The company was founded by Ming-Chu Hsu in 2001 and is headquartered in Taipei, Taiwan. | Health Technology |
| Eisai Medical Research, Inc. |
